DF Dent & Co’s Mesa Laboratories MLAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-54,556
| Closed | -$5.73M | – | 262 |
|
|
2023
Q3 | $5.73M | Buy |
54,556
+258
| +0.5% | +$33.1K | 0.08% | 95 |
|
|
2023
Q2 | $6.98M | Sell |
54,298
-2,396
| -4% | -$365K | 0.09% | 90 |
|
|
2023
Q1 | $9.9M | Buy |
56,694
+5,593
| +11% | +$1M | 0.14% | 82 |
|
|
2022
Q4 | $8.49M | Sell |
51,101
-3,165
| -6% | -$496K | 0.13% | 83 |
|
|
2022
Q3 | $7.64M | Sell |
54,266
-1,203
| -2% | -$219K | 0.12% | 84 |
|
|
2022
Q2 | $11.3M | Buy |
55,469
+4,044
| +8% | +$885K | 0.16% | 76 |
|
|
2022
Q1 | $13.1M | Sell |
51,425
-9,402
| -15% | -$2.55M | 0.15% | 76 |
|
|
2021
Q4 | $20M | Buy |
60,827
+256
| +0.4% | +$80.4K | 0.2% | 63 |
|
|
2021
Q3 | $18.3M | Buy |
60,571
+4,308
| +8% | +$1.22M | 0.19% | 66 |
|
|
2021
Q2 | $15.3M | Buy |
56,263
+3,247
| +6% | +$824K | 0.16% | 70 |
|
|
2021
Q1 | $12.9M | Buy |
53,016
+3,394
| +7% | +$934K | 0.15% | 72 |
|
|
2020
Q4 | $14.2M | Buy |
49,622
+4,009
| +9% | +$1.1M | 0.17% | 62 |
|
|
2020
Q3 | $11.6M | Buy |
45,613
+1,104
| +2% | +$262K | 0.16% | 60 |
|
|
2020
Q2 | $9.6M | Buy |
44,509
+2,517
| +6% | +$580K | 0.15% | 63 |
|
|
2020
Q1 | $9.49M | Buy |
41,992
+1,700
| +4% | +$419K | 0.18% | 54 |
|
|
2019
Q4 | $10M | Buy |
40,292
+540
| +1% | +$126K | 0.17% | 54 |
|
|
2019
Q3 | $9.45M | Buy |
39,752
+13,719
| +53% | +$3.17M | 0.17% | 52 |
|
|
2019
Q2 | $6.36M | Buy |
26,033
+272
| +1% | +$63.3K | 0.12% | 68 |
|
|
2019
Q1 | $5.94M | Buy |
25,761
+18,581
| +259% | +$4.2M | 0.12% | 71 |
|
|
2018
Q4 | $1.5M | Sell |
7,180
-3,507
| -33% | -$684K | 0.04% | 113 |
|
|
2018
Q3 | $1.98M | Buy |
10,687
+2,159
| +25% | +$435K | 0.04% | 106 |
|
|
2018
Q2 | $1.8M | Sell |
8,528
-2,680
| -24% | -$469K | 0.04% | 108 |
|
|
2018
Q1 | $1.66M | Buy |
11,208
+276
| +3% | +$37.6K | 0.04% | 107 |
|
|
2017
Q4 | $1.36M | Buy |
10,932
+396
| +4% | +$55.4K | 0.03% | 91 |
|
|
2017
Q3 | $1.57M | Buy |
10,536
+2,042
| +24% | +$288K | 0.04% | 80 |
|
|
2017
Q2 | $1.22M | Buy |
8,494
+2,346
| +38% | +$333K | 0.03% | 82 |
|
|
2017
Q1 | $754K | Buy |
6,148
+1,867
| +44% | +$229K | 0.02% | 93 |
|
|
2016
Q4 | $525K | Buy |
4,281
+607
| +17% | +$75.8K | 0.01% | 121 |
|
|
2016
Q3 | $420K | Buy |
+3,674
| New | +$419K | 0.01% | 118 |
|
Other funds holding MLAB
DF Dent & Co's MLAB Position: Q4 2023 in Review
DF Dent & Co sold out of Mesa Laboratories (MLAB) in Q4 2023, closing a stake of 54,556 shares — an estimated $5.73M sold.
DF Dent & Co first reported a position in MLAB in Q3 2016 and held it in 29 quarters. The position peaked at $20M in Q4 2021. 158 funds tracked by Wall St. Rank hold MLAB as of Q4 2023.
- DF Dent & Co reported no remaining Mesa Laboratories position as of Q4 2023 after selling out during the quarter.
- DF Dent & Co sold 54,556 Mesa Laboratories shares in Q4 2023, an estimated $5.73M.
- DF Dent & Co first reported a position in Mesa Laboratories in Q3 2016 and held it in 29 quarters.
- DF Dent & Co's Mesa Laboratories position peaked at $20M in Q4 2021.
- 158 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2023.
Based on DF Dent & Co's 13F filing for Q4 2023, filed 14 Feb 2024.